BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 2155101)

  • 1. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
    Krozowski ZS; Funder JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding and biological activity of 18-oxocortisol.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
    Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
    Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
    Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone".
    Krozowski Z; Funder JW
    Endocrinology; 1981 Oct; 109(4):1221-4. PubMed ID: 6269837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
    Wambach G; Casals-Stenzel J
    Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptors in the rat lung.
    Krozowski Z; Funder JW
    Endocrinology; 1981 Dec; 109(6):1811-3. PubMed ID: 6273117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies.
    Sheppard KE; Funder JW
    J Steroid Biochem; 1987 Dec; 28(6):737-42. PubMed ID: 2826920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
    Yamakawa M; Ezumi K; Shiro M; Nakai H; Kamata S; Matsui T; Haga N
    Mol Pharmacol; 1986 Dec; 30(6):585-9. PubMed ID: 3023811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 19-Nor progesterone is a mineralocorticoid agonist.
    Funder JW; Adam WR
    Endocrinology; 1981 Jul; 109(1):313-5. PubMed ID: 6263590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation.
    Coirini H; Marusic ET; De Nicola AF; Rainbow TC; McEwen BS
    Neuroendocrinology; 1983 Nov; 37(5):354-60. PubMed ID: 6316188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone receptor measurements during changes in dietary sodium.
    Grekin RJ; Sider RS
    Endocrinology; 1981 Jan; 108(1):109-12. PubMed ID: 6450676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.